DeSantis’ Canadian drug import plan hasn’t begun after FDA approval

Florida's initiative to import lower-cost prescription drugs from Canada, which received FDA approval nearly a year ago, has not yet commenced. Governor Ron DeSantis heralded the FDA's support as a significant achievement against a pharmaceutical industry that fears it may increase counterfeit drug risks. The importation program application was submitted in November 2020, following the Trump administration's allowance for states to pursue such initiatives. DeSantis has publicly criticized the pace of federal approvals under President Biden, even resorting to legal action over what he deemed reckless delays. Meanwhile, former President Trump continues to advocate for affordable drug prices, suggesting that he would push for similar measures if re-elected.

The uncertainty surrounding the program's implementation is compounded by the silence from DeSantis' health officials, who have not addressed questions about the initiative’s status. Colorado is also in pursuit of FDA approval for its own importation program, indicating that Florida's situation is part of a broader national conversation on drug pricing. The ongoing delays and lack of communication highlight significant challenges in executing a plan aimed at reducing healthcare costs for Floridians.